Find a Tender
Record
Official procurement procedure
NHS England procurement for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS England procurement for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives". Published status: awardUpdate. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | Recorded No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
46.5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 881 active published awards; 872 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
StatusNot published | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published13 Mar 2024, 14:38 GMT | Last source update13 Mar 2024, 14:38 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-04482a | ||
What is being bought
No description published
What changed
From the official release history
- Official notice release published
13 Mar 2024, 14:38 GMT - Buyer information updated
13 Mar 2024, 14:38 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedThis procurement will be conducted by NHS Arden & Greater East Midlands Commissioning Support Unit on behalf of NHS England Specialised Commissioning.<br/>Contract(s) entered into pursuant to this procurement will be between the successful supplier(s) and NHS England (National Health Service Commissioning Board).<br/>Organisations wishing to participate in the procurement must have at least one Direct Acting Antiviral (DAA) for the treatment of Hepatitis C within their product portfolio. There is no restriction on the number of DAA products that bidders can offer for, or that can be included in the contract(s).<br/>Contract(s) awarded pursuant the procurement exercise are for use by the Department of Health, Public Health England, the NHS in England; and be used by private sector contractors and agents working on behalf of the aforementioned<br/>Appointed suppliers will be responsible for (i) the supply of Hepatitis C DAA treatments and (ii) the provision of Hepatitis C elimination initiatives and/or services to help identify and treat Hepatitis C patients so as to accelerate the elimination of Hepatitis C in England from 1st October 2018. The duration of any Contract(s) awarded will be for an initial period of three (3) years, with an option to extend (at the sole discretion of the contracting authority) for an additional period or periods up to two (2) years.<br/>Further information, including details regarding the Lots, is set out in the procurement documents which are available to download (see below for details)<br/>The contracting authority intends to use the NHS Arden & Greater East Midlands Commissioning Support Unit e-procurement portal in this procurement exercise.<br/>i) To Register - log onto the portal at https://ardengemcsu.bravosolution.co.uk (registration and use of the website is free of charge).<br/>ii) Express interest by:<br/>a) selecting response to advert and PQQ (ref: pqq_483) and ITT (ref: itt_958)<br/>b) select Open Access ITT<br/>c) search for and access listing related to this contract and view details<br/>d) click on Express Interest link<br/>iii) Once you have expressed interest, access the My ITTs page where you can download and complete the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
13 Mar 2024, 14:38 GMT - Award active
Not published · Not published - Contract active
Signed 1 May 2019, 00:00 BST · £1,200,000,000
Commercial outcome and competition
Awards Gilead Sciences Limited Not published · Not published · active |
Contracts NHS England procurement for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives £1,200,000,000 · signed 1 May 2019, 00:00 BST · active Contract period: 1 May 2019, 00:00 BST — 31 Mar 2024, 23:59 BST |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-FTS-3022Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published